Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy.
Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 2 institutions in 1 country.
Alan Y HsuDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.ORCID 0000-0003-2125-9495
Chih-Ying LinDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Chun-Ju LinDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.ORCID 0000-0002-7880-9198
Chun-Ting LaiDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Ning-Yi HsiaDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.ORCID 0000-0002-9398-1316
Jane-Ming LinDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Peng-Tai TienDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.ORCID 0000-0002-9099-3151
Ping-Ping MengDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Wei-Ning KuDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Wen-Lu ChenDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Yi-Yu TsaiDepartment of Ophthalmology, China Medical University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 40447, Taiwan.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. · full record | OpenQuestion